Danske Bank A S Acquires Shares of 834,615 Corteva, Inc. $CTVA

Danske Bank A S bought a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 834,615 shares of the company’s stock, valued at approximately $70,684,000.

Other hedge funds have also modified their holdings of the company. Elevation Wealth Partners LLC lifted its stake in shares of Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after buying an additional 261 shares in the last quarter. Clearstead Trust LLC acquired a new position in Corteva during the second quarter worth about $31,000. JPL Wealth Management LLC purchased a new stake in Corteva during the 3rd quarter valued at about $25,000. N.E.W. Advisory Services LLC acquired a new stake in Corteva in the 2nd quarter valued at about $33,000. Finally, Westfuller Advisors LLC raised its holdings in Corteva by 2,764.3% in the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after acquiring an additional 387 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Up 2.6%

Corteva stock opened at $77.97 on Wednesday. The company has a market capitalization of $52.02 billion, a PE ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97. The firm has a 50 day moving average price of $81.84 and a 200 day moving average price of $80.12.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the prior year, the firm earned $2.20 earnings per share. The firm’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is 47.68%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Oppenheimer boosted their target price on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, July 23rd. Royal Bank Of Canada increased their price target on Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a report on Tuesday, July 21st. Weiss Ratings downgraded Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Citigroup boosted their price objective on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Finally, Morgan Stanley upped their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.